The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"SMAD MH1 domain
".
FunFam 2: Mothers against decapentaplegic homolog
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 46 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
23 |
B1PS58 (/IPI)
B1PS59 (/IPI)
F1QS48 (/IPI)
O62609 (/IPI)
O70437 (/IPI)
P97471 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
(13 more) |
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
18 |
O62609 (/IDA)
P97471 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(8 more) |
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
16 |
Q13485 (/ISA)
Q13485 (/ISA)
Q13485 (/ISA)
Q13485 (/ISA)
Q13485 (/ISA)
Q13485 (/ISA)
Q13485 (/ISA)
Q13485 (/ISA)
Q13485 (/ISA)
Q13485 (/ISA)
(6 more) |
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
16 |
Q13485 (/ISM)
Q13485 (/ISM)
Q13485 (/ISM)
Q13485 (/ISM)
Q13485 (/ISM)
Q13485 (/ISM)
Q13485 (/ISM)
Q13485 (/ISM)
Q13485 (/ISM)
Q13485 (/ISM)
(6 more) |
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
16 |
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
(6 more) |
Proximal promoter sequence-specific DNA binding GO:0000987
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter. The proximal promoter is in cis with and relatively close to the core promoter.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Transcription coregulator activity GO:0003712
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to either activate or repress the transcription of specific genes. Coregulators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. A third class modulates interactions of DNA-binding transcription factor with other transcription coregulators.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Transforming growth factor beta receptor, common-partner cytoplasmic mediator activity GO:0030616
A TGF-beta cytoplasmic mediator that forms a complex with a phosphorylated pathway-specific mediator. The heterocomplex translocates to the nucleus to regulate transcription.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
16 |
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
(6 more) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
16 |
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
(6 more) |
Sulfate binding GO:0043199
Interacting selectively and non-covalently with sulfate, SO4(2-), a negatively charged small molecule.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
I-SMAD binding GO:0070411
Interacting selectively and non-covalently with an inhibitory SMAD signaling protein.
|
16 |
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
(6 more) |
R-SMAD binding GO:0070412
Interacting selectively and non-covalently with a receptor-regulated SMAD signaling protein.
|
16 |
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
(6 more) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
4 | B1PS58 (/IDA) B1PS59 (/IDA) F1QS48 (/IDA) P97471 (/IDA) |
Enhancer sequence-specific DNA binding GO:0001158
Interacting selectively and non-covalently with a specific sequence of DNA that is part of an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
|
3 | O17532 (/IDA) Q95QI7 (/IDA) Q95QI8 (/IDA) |
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
|
3 | B1PS58 (/IPI) B1PS59 (/IPI) F1QS48 (/IPI) |
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
|
2 | O62609 (/IDA) P97471 (/IDA) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
2 | O70437 (/IDA) P97471 (/IDA) |
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
|
1 | P97471 (/IGI) |
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
|
1 | P97471 (/ISO) |
Proximal promoter sequence-specific DNA binding GO:0000987
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter. The proximal promoter is in cis with and relatively close to the core promoter.
|
1 | P97471 (/ISO) |
RNA polymerase II transcription factor binding GO:0001085
Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II.
|
1 | P97471 (/IPI) |
DNA-binding transcription repressor activity, RNA polymerase II-specific GO:0001227
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to repress or decrease transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
1 | O62609 (/IDA) |
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
1 | P97471 (/IGI) |
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
1 | P97471 (/ISO) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
1 | P97471 (/ISO) |
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
|
1 | P97471 (/IDA) |
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
|
1 | P97471 (/IDA) |
Transcription coregulator activity GO:0003712
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to either activate or repress the transcription of specific genes. Coregulators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. A third class modulates interactions of DNA-binding transcription factor with other transcription coregulators.
|
1 | P97471 (/ISO) |
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
|
1 | P97471 (/IPI) |
Transforming growth factor beta receptor, common-partner cytoplasmic mediator activity GO:0030616
A TGF-beta cytoplasmic mediator that forms a complex with a phosphorylated pathway-specific mediator. The heterocomplex translocates to the nucleus to regulate transcription.
|
1 | P97471 (/ISO) |
Filamin binding GO:0031005
Interacting selectively and non-covalently with a filamin, any member of a family of high molecular mass cytoskeletal proteins that crosslink actin filaments to form networks and stress fibers. Filamins contain an amino-terminal alpha-actinin-like actin binding domain, which is followed by a rod-domain composed of 4 to 24 100-residue repetitive segments including a carboxy-terminal dimerization domain.
|
1 | O70437 (/IPI) |
Filamin binding GO:0031005
Interacting selectively and non-covalently with a filamin, any member of a family of high molecular mass cytoskeletal proteins that crosslink actin filaments to form networks and stress fibers. Filamins contain an amino-terminal alpha-actinin-like actin binding domain, which is followed by a rod-domain composed of 4 to 24 100-residue repetitive segments including a carboxy-terminal dimerization domain.
|
1 | P97471 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
1 | P97471 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | P97471 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | P97471 (/ISO) |
Sulfate binding GO:0043199
Interacting selectively and non-covalently with sulfate, SO4(2-), a negatively charged small molecule.
|
1 | P97471 (/ISO) |
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
|
1 | P97471 (/ISO) |
SMAD binding GO:0046332
Interacting selectively and non-covalently with a SMAD signaling protein.
|
1 | O70437 (/IPI) |
SMAD binding GO:0046332
Interacting selectively and non-covalently with a SMAD signaling protein.
|
1 | P97471 (/ISO) |
I-SMAD binding GO:0070411
Interacting selectively and non-covalently with an inhibitory SMAD signaling protein.
|
1 | P97471 (/ISO) |
R-SMAD binding GO:0070412
Interacting selectively and non-covalently with a receptor-regulated SMAD signaling protein.
|
1 | P97471 (/ISO) |
Molecular function regulator GO:0098772
A molecular function that modulates the activity of a gene product or complex. Examples include enzyme regulators and channel regulators.
|
1 | P97471 (/IMP) |
There are 198 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
18 |
O62609 (/IDA)
P97471 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(8 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
17 |
P97471 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(7 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
17 |
O62609 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(7 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
17 |
P97471 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(7 more) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
17 |
O62609 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(7 more) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
16 |
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(6 more) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Atrioventricular valve formation GO:0003190
The developmental process pertaining to the initial formation of the atrioventricular valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Left ventricular cardiac muscle tissue morphogenesis GO:0003220
The process in which the anatomical structures of left cardiac ventricle muscle are generated and organized.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Positive regulation of cell proliferation involved in heart valve morphogenesis GO:0003251
Any process that increases the rate, frequency or extent of cell proliferation that contributes to the shaping of a heart valve.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Cellular iron ion homeostasis GO:0006879
Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(6 more) |
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Negative regulation of cardiac muscle hypertrophy GO:0010614
Any process that decreases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Protein deubiquitination GO:0016579
The removal of one or more ubiquitin groups from a protein.
|
16 |
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(6 more) |
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(6 more) |
Positive regulation of transforming growth factor beta receptor signaling pathway GO:0030511
Any process that activates or increases the frequency, rate or extent of TGF-beta receptor signaling pathway activity.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Regulation of transforming growth factor beta2 production GO:0032909
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Somatic stem cell population maintenance GO:0035019
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
|
16 |
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(6 more) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Atrioventricular canal development GO:0036302
The progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart connecting the atrium to the cardiac ventricle.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
16 |
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(6 more) |
Positive regulation of histone H3-K4 methylation GO:0051571
Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Ventricular septum morphogenesis GO:0060412
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Endocardial cell differentiation GO:0060956
The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of an endocardial cell. An endocardial cell is a specialized endothelial cell that makes up the endocardium portion of the heart. The endocardium is the innermost layer of tissue of the heart, and lines the heart chambers.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Secondary palate development GO:0062009
The biological process whose specific outcome is the progression of the secondary palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The secondary palate is the part of the palate formed from the fusion of the two palatine shelves, extensions of the maxillary prominences.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Interleukin-6-mediated signaling pathway GO:0070102
A series of molecular signals initiated by the binding of interleukin-6 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Protein homotrimerization GO:0070207
The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Negative regulation of ERK1 and ERK2 cascade GO:0070373
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Response to transforming growth factor beta GO:0071559
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
16 |
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
Q13485 (/NAS)
(6 more) |
Positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus GO:1901522
Any positive regulation of transcription from RNA polymerase II promoter that is involved in cellular response to chemical stimulus.
|
16 |
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(6 more) |
Negative regulation of cardiac myofibril assembly GO:1905305
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac myofibril assembly.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Positive regulation of histone H3-K9 acetylation GO:2000617
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
|
16 |
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
Q13485 (/ISS)
(6 more) |
Imaginal disc-derived wing morphogenesis GO:0007476
The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying.
|
7 | O61458 (/IMP) O62609 (/IMP) O76259 (/IMP) O77069 (/IMP) Q7KPL1 (/IMP) Q8IMG6 (/IMP) Q9U010 (/IMP) |
Imaginal disc-derived leg morphogenesis GO:0007480
The process in which the anatomical structures of a leg derived from an imaginal disc are generated and organized. A leg is a limb on which an animal walks and stands. An example of this is found in Drosophila melanogaster.
|
7 | O61458 (/IMP) O62609 (/IMP) O76259 (/IMP) O77069 (/IMP) Q7KPL1 (/IMP) Q8IMG6 (/IMP) Q9U010 (/IMP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
7 | O61458 (/TAS) O62609 (/TAS) O76259 (/TAS) O77069 (/TAS) Q7KPL1 (/TAS) Q8IMG6 (/TAS) Q9U010 (/TAS) |
Ovarian follicle cell development GO:0030707
The process that occurs during oogenesis involving the ovarian follicle cells, somatic cells which surround the germ cells of an ovary. An example of this is found in Drosophila melanogaster.
|
7 | O61458 (/IMP) O62609 (/IMP) O76259 (/IMP) O77069 (/IMP) Q7KPL1 (/IMP) Q8IMG6 (/IMP) Q9U010 (/IMP) |
Germ-line stem cell population maintenance GO:0030718
Any process by which an organism or tissue maintains a population of germ-line stem cells.
|
7 | O61458 (/IMP) O62609 (/IMP) O76259 (/IMP) O77069 (/IMP) Q7KPL1 (/IMP) Q8IMG6 (/IMP) Q9U010 (/IMP) |
Retinal ganglion cell axon guidance GO:0031290
The process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues.
|
7 | O61458 (/IMP) O62609 (/IMP) O76259 (/IMP) O77069 (/IMP) Q7KPL1 (/IMP) Q8IMG6 (/IMP) Q9U010 (/IMP) |
Somatic stem cell population maintenance GO:0035019
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
|
7 | O61458 (/IMP) O62609 (/IMP) O76259 (/IMP) O77069 (/IMP) Q7KPL1 (/IMP) Q8IMG6 (/IMP) Q9U010 (/IMP) |
Germ-line stem cell division GO:0042078
The self-renewing division of a germline stem cell to produce a daughter stem cell and a daughter germ cell, which will divide to form the gametes.
|
7 | O61458 (/IMP) O62609 (/IMP) O76259 (/IMP) O77069 (/IMP) Q7KPL1 (/IMP) Q8IMG6 (/IMP) Q9U010 (/IMP) |
Negative regulation of salivary gland boundary specification GO:0045705
Any process that stops, prevents, or reduces the frequency, rate or extent of salivary gland determination.
|
7 | O61458 (/TAS) O62609 (/TAS) O76259 (/TAS) O77069 (/TAS) Q7KPL1 (/TAS) Q8IMG6 (/TAS) Q9U010 (/TAS) |
Neuron development GO:0048666
The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
|
7 | O61458 (/IMP) O62609 (/IMP) O76259 (/IMP) O77069 (/IMP) Q7KPL1 (/IMP) Q8IMG6 (/IMP) Q9U010 (/IMP) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
3 | O17532 (/IGI) Q95QI7 (/IGI) Q95QI8 (/IGI) |
Skeletal muscle tissue development GO:0007519
The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are: the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm and the establishment of functional neuromuscular junctions with motor neurons. At this stage they can be regarded as mature muscle fibers.
|
3 | B1PS58 (/IMP) B1PS59 (/IMP) F1QS48 (/IMP) |
Dauer larval development GO:0040024
The process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
3 | O17532 (/IMP) Q95QI7 (/IMP) Q95QI8 (/IMP) |
Regulation of pharyngeal pumping GO:0043051
Any process that modulates the contraction and relaxation movements of the pharyngeal muscle that mediates feeding in nematodes.
|
3 | O17532 (/IGI) Q95QI7 (/IGI) Q95QI8 (/IGI) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
3 | B1PS58 (/IGI) B1PS59 (/IGI) F1QS48 (/IGI) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
3 | B1PS58 (/IMP) B1PS59 (/IMP) F1QS48 (/IMP) |
Cardiac muscle tissue development GO:0048738
The process whose specific outcome is the progression of cardiac muscle over time, from its formation to the mature structure.
|
3 | B1PS58 (/IMP) B1PS59 (/IMP) F1QS48 (/IMP) |
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
|
3 | O17532 (/IGI) Q95QI7 (/IGI) Q95QI8 (/IGI) |
Convergent extension GO:0060026
The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis.
|
3 | B1PS58 (/IGI) B1PS59 (/IGI) F1QS48 (/IGI) |
Convergent extension GO:0060026
The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis.
|
3 | B1PS58 (/IMP) B1PS59 (/IMP) F1QS48 (/IMP) |
Regulation of dauer larval development GO:0061065
Any process that modulates the rate, frequency, or extent of dauer larval development, the process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
3 | O17532 (/IGI) Q95QI7 (/IGI) Q95QI8 (/IGI) |
Protein trimerization GO:0070206
The formation of a protein trimer, a macromolecular structure consisting of three noncovalently associated identical or nonidentical subunits.
|
3 | B1PS58 (/IPI) B1PS59 (/IPI) F1QS48 (/IPI) |
Determination of adult lifespan GO:0008340
The control of viability and duration in the adult phase of the life-cycle.
|
2 | P45897 (/IMP) Q95QI7 (/IMP) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | O62609 (/IMP) P97471 (/IMP) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | O62609 (/IDA) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | P97471 (/IMP) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
1 | O70437 (/IEP) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
1 | P97471 (/IGI) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
1 | P97471 (/IMP) |
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
|
1 | O70437 (/IMP) |
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
|
1 | P97471 (/ISO) |
Branching involved in ureteric bud morphogenesis GO:0001658
The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
1 | P97471 (/IGI) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P97471 (/ISO) |
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
|
1 | P97471 (/IMP) |
Gastrulation with mouth forming second GO:0001702
A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
|
1 | P97471 (/IMP) |
Compound eye morphogenesis GO:0001745
The morphogenetic process in which the anatomical structures of the compound eye are generated and organized. The adult compound eye is a precise assembly of 700-800 ommatidia. Each ommatidium is composed of 20 cells, identified by cell type and position. An example of compound eye morphogenesis is found in Drosophila melanogaster.
|
1 | O62609 (/IMP) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | P97471 (/IMP) |
Nematode larval development GO:0002119
The process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.
|
1 | P45897 (/IMP) |
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
|
1 | P97471 (/IGI) |
Atrioventricular valve formation GO:0003190
The developmental process pertaining to the initial formation of the atrioventricular valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
|
1 | P97471 (/IGI) |
Epithelial to mesenchymal transition involved in endocardial cushion formation GO:0003198
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell that will contribute to the formation of the endocardial cushion.
|
1 | P97471 (/IMP) |
Left ventricular cardiac muscle tissue morphogenesis GO:0003220
The process in which the anatomical structures of left cardiac ventricle muscle are generated and organized.
|
1 | P97471 (/IMP) |
Positive regulation of cell proliferation involved in heart valve morphogenesis GO:0003251
Any process that increases the rate, frequency or extent of cell proliferation that contributes to the shaping of a heart valve.
|
1 | P97471 (/IMP) |
Cardiac septum development GO:0003279
The progression of a cardiac septum over time, from its initial formation to the mature structure.
|
1 | P97471 (/IGI) |
Brainstem development GO:0003360
The progression of the brainstem from its formation to the mature structure. The brainstem is the part of the brain that connects the brain with the spinal cord.
|
1 | P97471 (/IMP) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | P97471 (/IDA) |
Cellular iron ion homeostasis GO:0006879
Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
|
1 | P97471 (/IMP) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P97471 (/IGI) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P97471 (/ISO) |
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
|
1 | P97471 (/ISO) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
1 | P97471 (/IMP) |
Single fertilization GO:0007338
The union of male and female gametes to form a zygote.
|
1 | P97471 (/IGI) |
Gastrulation GO:0007369
A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
1 | P97471 (/IMP) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
1 | P97471 (/IMP) |
Endoderm development GO:0007492
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
|
1 | P97471 (/IMP) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
1 | P97471 (/IMP) |
Parturition GO:0007567
The reproductive process in which the parent is separated from its offspring either by giving birth to live young or by laying eggs.
|
1 | P45897 (/IGI) |
Parturition GO:0007567
The reproductive process in which the parent is separated from its offspring either by giving birth to live young or by laying eggs.
|
1 | P45897 (/IMP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | O70437 (/IEP) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
1 | P97471 (/IMP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | P97471 (/IGI) |
Determination of adult lifespan GO:0008340
The control of viability and duration in the adult phase of the life-cycle.
|
1 | P45897 (/IGI) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
1 | P97471 (/IMP) |
Female gonad development GO:0008585
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
|
1 | P97471 (/IGI) |
Anatomical structure morphogenesis GO:0009653
The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form.
|
1 | P97471 (/IMP) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
1 | P45897 (/IGI) |
Dorsal/ventral axis specification GO:0009950
The establishment, maintenance and elaboration of the dorsal/ventral axis. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
1 | O62609 (/IMP) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
1 | P97471 (/IMP) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
1 | O62609 (/IMP) |
Negative regulation of cardiac muscle hypertrophy GO:0010614
Any process that decreases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
1 | P97471 (/IMP) |
Positive regulation of cardiac muscle cell apoptotic process GO:0010666
Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
|
1 | O70437 (/IMP) |
Positive regulation of cardiac muscle cell apoptotic process GO:0010666
Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
|
1 | P97471 (/ISO) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P97471 (/IMP) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | P97471 (/IMP) |
Neural crest cell differentiation GO:0014033
The process in which a relatively unspecialized cell acquires specialized features of a neural crest cell.
|
1 | P97471 (/IMP) |
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
|
1 | P97471 (/ISO) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
1 | P97471 (/IMP) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | P45897 (/IGI) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | P45897 (/IMP) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
1 | P97471 (/ISO) |
Adrenal gland development GO:0030325
The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells.
|
1 | O70437 (/IEP) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | O62609 (/IGI) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P97471 (/ISO) |
Positive regulation of transforming growth factor beta receptor signaling pathway GO:0030511
Any process that activates or increases the frequency, rate or extent of TGF-beta receptor signaling pathway activity.
|
1 | P97471 (/ISO) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
1 | P97471 (/ISO) |
Somite rostral/caudal axis specification GO:0032525
The establishment, maintenance and elaboration of the rostro-caudal axis of a somite, prior to the morphological formation of a somite boundary.
|
1 | P97471 (/IMP) |
Regulation of transforming growth factor beta2 production GO:0032909
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
|
1 | P97471 (/ISO) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | O62609 (/IDA) |
Positive regulation of luteinizing hormone secretion GO:0033686
Any process that activates or increases the frequency, rate or extent of the regulated release of luteinizing hormone.
|
1 | P97471 (/IGI) |
Positive regulation of luteinizing hormone secretion GO:0033686
Any process that activates or increases the frequency, rate or extent of the regulated release of luteinizing hormone.
|
1 | P97471 (/IMP) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
1 | P97471 (/ISO) |
Atrioventricular canal development GO:0036302
The progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart connecting the atrium to the cardiac ventricle.
|
1 | P97471 (/IGI) |
Positive regulation of multicellular organism growth GO:0040018
Any process that activates or increases the frequency, rate or extent of growth of an organism to reach its usual body size.
|
1 | P45897 (/IGI) |
Positive regulation of multicellular organism growth GO:0040018
Any process that activates or increases the frequency, rate or extent of growth of an organism to reach its usual body size.
|
1 | P45897 (/IMP) |
Dauer larval development GO:0040024
The process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
1 | P45897 (/IGI) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
1 | O70437 (/IEP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
1 | O70437 (/IMP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
1 | P97471 (/ISO) |
Endothelial cell activation GO:0042118
The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
1 | P97471 (/IMP) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
1 | P97471 (/IGI) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
1 | P97471 (/IMP) |
Negative regulation of protein catabolic process GO:0042177
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
1 | O70437 (/IMP) |
Negative regulation of protein catabolic process GO:0042177
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
1 | P97471 (/ISO) |
Regulation of mesodermal cell fate specification GO:0042661
Any process that modulates the frequency, rate or extent of mesoderm cell fate specification.
|
1 | P45897 (/IGI) |
Embryonic digit morphogenesis GO:0042733
The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe.
|
1 | P97471 (/IMP) |
Nematode male tail tip morphogenesis GO:0045138
The process in which the anatomical structure of the adult male tail tip is generated and organized. In some species of rhabitid nematodes, the male tail tip undergoes a morphological change such that the most posterior hypodermal cells in the tail (hyp8-11 in C. elegans) fuse and retract anteriorly, changing the shape of the tail from a pointed, tapered cone, or spike, to a rounded, blunt dome.
|
1 | P45897 (/IGI) |
Nematode male tail tip morphogenesis GO:0045138
The process in which the anatomical structure of the adult male tail tip is generated and organized. In some species of rhabitid nematodes, the male tail tip undergoes a morphological change such that the most posterior hypodermal cells in the tail (hyp8-11 in C. elegans) fuse and retract anteriorly, changing the shape of the tail from a pointed, tapered cone, or spike, to a rounded, blunt dome.
|
1 | P45897 (/IMP) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
1 | P45897 (/IMP) |
Positive regulation of cell size GO:0045793
Any process that increases cell size.
|
1 | P45897 (/IMP) |
Positive regulation of synaptic growth at neuromuscular junction GO:0045887
Any process that activates or increases the frequency, rate or extent of synaptic growth at neuromuscular junction.
|
1 | O62609 (/IMP) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P97471 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P97471 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | P97471 (/IGI) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | P97471 (/IMP) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | P97471 (/ISO) |
Positive regulation of organ growth GO:0046622
Any process that activates or increases the frequency, rate or extent of growth of an organ of an organism.
|
1 | P45897 (/IMP) |
Positive regulation of follicle-stimulating hormone secretion GO:0046881
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone.
|
1 | P97471 (/IGI) |
Positive regulation of follicle-stimulating hormone secretion GO:0046881
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone.
|
1 | P97471 (/IMP) |
Mesendoderm development GO:0048382
The process whose specific outcome is the progression of the mesendoderm over time, from its formation to the mature structure. In animal embryos, mesendoderm development gives rise to both mesoderm and endoderm tissues.
|
1 | P97471 (/IMP) |
Developmental growth GO:0048589
The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
|
1 | P97471 (/IMP) |
Neuron fate commitment GO:0048663
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
|
1 | P97471 (/IMP) |
Tissue morphogenesis GO:0048729
The process in which the anatomical structures of a tissue are generated and organized.
|
1 | P97471 (/IMP) |
Sebaceous gland development GO:0048733
The process whose specific outcome is the progression of the sebaceous gland over time, from its formation to the mature structure.
|
1 | P97471 (/IMP) |
Formation of anatomical boundary GO:0048859
The process in which the limits of an anatomical structure are generated. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
|
1 | P97471 (/IMP) |
Regulation of binding GO:0051098
Any process that modulates the frequency, rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
|
1 | P97471 (/IDA) |
Positive regulation of histone H3-K4 methylation GO:0051571
Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3.
|
1 | P97471 (/IMP) |
Regulation of hair follicle development GO:0051797
Any process that modulates the frequency, rate or extent of hair follicle development.
|
1 | P97471 (/IMP) |
Uterus development GO:0060065
The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure.
|
1 | P97471 (/IGI) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | P97471 (/IMP) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
1 | P97471 (/ISO) |
Ventricular septum morphogenesis GO:0060412
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
|
1 | P97471 (/IMP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
1 | P97471 (/IMP) |
Endocardial cell differentiation GO:0060956
The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of an endocardial cell. An endocardial cell is a specialized endothelial cell that makes up the endocardium portion of the heart. The endocardium is the innermost layer of tissue of the heart, and lines the heart chambers.
|
1 | P97471 (/IMP) |
Female gonad morphogenesis GO:0061040
The process in which a female gonad is generated and organized.
|
1 | P97471 (/IMP) |
Positive regulation of dauer larval development GO:0061066
Any process that increases the rate, frequency, or extent of dauer larval development, the process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
1 | Q95QI7 (/IMP) |
Pri-miRNA transcription by RNA polymerase II GO:0061614
The cellular synthesis of primary microRNA (pri-miRNA) transcripts from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. pri-miRNA transcripts are subsequently processed to produce the ~22nt miRNAs that function in gene regulation.
|
1 | P97471 (/IMP) |
Secondary palate development GO:0062009
The biological process whose specific outcome is the progression of the secondary palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The secondary palate is the part of the palate formed from the fusion of the two palatine shelves, extensions of the maxillary prominences.
|
1 | P97471 (/IMP) |
Interleukin-6-mediated signaling pathway GO:0070102
A series of molecular signals initiated by the binding of interleukin-6 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P97471 (/IDA) |
Protein homotrimerization GO:0070207
The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
|
1 | P97471 (/ISO) |
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade may involve 4 different kinases, as it can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
1 | O70437 (/IMP) |
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade may involve 4 different kinases, as it can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
1 | P97471 (/ISO) |
Negative regulation of ERK1 and ERK2 cascade GO:0070373
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
1 | P97471 (/IMP) |
Cellular response to glucose stimulus GO:0071333
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | O70437 (/IDA) |
Cellular response to glucose stimulus GO:0071333
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | P97471 (/ISO) |
Cellular response to pheromone GO:0071444
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pheromone stimulus.
|
1 | Q95QI7 (/IGI) |
Response to transforming growth factor beta GO:0071559
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
1 | P97471 (/ISO) |
Metanephric mesenchyme morphogenesis GO:0072133
The process in which the anatomical structures of a metanephric mesenchymal tissue are generated and organized. Metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros.
|
1 | P97471 (/IMP) |
Nephrogenic mesenchyme morphogenesis GO:0072134
The process in which the anatomical structures of a nephrogenic mesenchymal tissue are generated and organized. Nephrogenic mesenchyme is the tissue made up of loosely connected mesenchymal cells in the nephron.
|
1 | P97471 (/IMP) |
Seminiferous tubule development GO:0072520
The reproductive developmental process whose specific outcome is the progression of the seminiferous tubule over time, from its formation to the mature structure. Seminiferous tubules are ducts located in the testicles, and are the specific location of meiosis, and the subsequent creation of gametes, namely spermatozoa.
|
1 | P97471 (/IMP) |
Negative regulation of cardiac myofibril assembly GO:1905305
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac myofibril assembly.
|
1 | P97471 (/IMP) |
Positive regulation of histone H3-K9 acetylation GO:2000617
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
|
1 | P97471 (/IMP) |
There are 32 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
49 |
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
(39 more) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
48 |
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
(38 more) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
48 |
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
A0A024R274 (/IDA)
(38 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
25 |
B1PS58 (/IDA)
B1PS59 (/IDA)
F1QS48 (/IDA)
O17532 (/IDA)
O62609 (/IDA)
O70437 (/IDA)
P97471 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(15 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
21 |
O17532 (/IDA)
O70437 (/IDA)
P97471 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(11 more) |
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
|
18 |
O62609 (/IPI)
P97471 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
Q13485 (/IPI)
(8 more) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
17 |
P97471 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(7 more) |
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
16 |
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
Q13485 (/TAS)
(6 more) |
Activin responsive factor complex GO:0032444
A transcriptionally active complex that binds to an activin response element (ARE) in the promoter of target genes, and is composed of two SMAD2 proteins, one SMAD4 protein and a Forkhead activin signal transducer (FAST) transcription factor.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
SMAD protein complex GO:0071141
A protein complex that consists of only SMAD proteins; may be homomeric or heteromeric. Heteromeric complexes act as transcription factors while homomeric complexes exist but are transcriptionally inactive. Hetero- versus homotrimerization is largely enthalpy driven.
|
16 |
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
Q13485 (/IDA)
(6 more) |
SMAD protein complex GO:0071141
A protein complex that consists of only SMAD proteins; may be homomeric or heteromeric. Heteromeric complexes act as transcription factors while homomeric complexes exist but are transcriptionally inactive. Hetero- versus homotrimerization is largely enthalpy driven.
|
16 |
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
Q13485 (/IMP)
(6 more) |
Condensed chromosome GO:0000793
A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure.
|
3 | O17532 (/IDA) Q95QI7 (/IDA) Q95QI8 (/IDA) |
SMAD protein complex GO:0071141
A protein complex that consists of only SMAD proteins; may be homomeric or heteromeric. Heteromeric complexes act as transcription factors while homomeric complexes exist but are transcriptionally inactive. Hetero- versus homotrimerization is largely enthalpy driven.
|
3 | B1PS58 (/IPI) B1PS59 (/IPI) F1QS48 (/IPI) |
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
|
1 | P97471 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | O62609 (/IPI) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | P97471 (/ISO) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
1 | P97471 (/ISO) |
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
|
1 | P97471 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | O62609 (/HDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | P97471 (/ISO) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
1 | P97471 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | P97471 (/ISO) |
Activin responsive factor complex GO:0032444
A transcriptionally active complex that binds to an activin response element (ARE) in the promoter of target genes, and is composed of two SMAD2 proteins, one SMAD4 protein and a Forkhead activin signal transducer (FAST) transcription factor.
|
1 | P97471 (/ISO) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
1 | O70437 (/IDA) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
1 | P97471 (/ISO) |
SMAD protein complex GO:0071141
A protein complex that consists of only SMAD proteins; may be homomeric or heteromeric. Heteromeric complexes act as transcription factors while homomeric complexes exist but are transcriptionally inactive. Hetero- versus homotrimerization is largely enthalpy driven.
|
1 | P97471 (/ISO) |
Heteromeric SMAD protein complex GO:0071144
A protein complex composed of SMAD family proteins, a transcription factor complex which binds to the promoters of target genes and recruits co-activators and histone acetyltransferases, facilitating transcription. Phosphorylation of the non-SMAD4 subunit(s) enables binding of SMAD4 to form heteromeric complexes that enter the nucleus to initiate gene transcription. DNA-binding specificity is conferred by other transcription factors binding to SMAD complexes. Interactions with coactivators or corepressors modulate their transcriptional activity. Can be heterotrimeric or heterodimeric.
|
1 | O62609 (/IDA) |
Heteromeric SMAD protein complex GO:0071144
A protein complex composed of SMAD family proteins, a transcription factor complex which binds to the promoters of target genes and recruits co-activators and histone acetyltransferases, facilitating transcription. Phosphorylation of the non-SMAD4 subunit(s) enables binding of SMAD4 to form heteromeric complexes that enter the nucleus to initiate gene transcription. DNA-binding specificity is conferred by other transcription factors binding to SMAD complexes. Interactions with coactivators or corepressors modulate their transcriptional activity. Can be heterotrimeric or heterodimeric.
|
1 | O62609 (/IPI) |
RNA polymerase II transcription repressor complex GO:0090571
A protein complex, located in the nucleus, that possesses activity that prevents or downregulates transcription from a RNA polymerase II promoter.
|
1 | O62609 (/IPI) |
RNA polymerase II transcription factor complex GO:0090575
A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II.
|
1 | P97471 (/IDA) |